Alterations of lung structure in experimental diabetes, and diabetes associated with hyperlipidaemia in hamsters

European Respiratory Journal

Volumn 10, Issue 8, 1997, Pages 1850-1858

  Popov, D ^a   Simionescu, M ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

Diabetes; Endothelium; Epithelial cells; Hyperlipidaemia; Lung

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; ENDOTHELIUM; EPITHELIUM CELL; EXPERIMENTAL DIABETES MELLITUS; FORCED EXPIRATORY VOLUME; GLUCOSE BLOOD LEVEL; HAMSTER; HYDROPHOBICITY; HYPERLIPIDEMIA; LUNG PARENCHYMA; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; BLOOD GLUCOSE; BLOOD VESSELS; BODY WEIGHT; CHOLESTEROL; CRICETINAE; DIABETES MELLITUS, EXPERIMENTAL; HYPERLIPIDEMIAS; LUNG; MALE; MESOCRICETUS; PULMONARY CIRCULATION;

EID: 0030827204     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10081850     Document Type: Article

References (32)

1. Sandler M, Bunn AE, Stewart RI. Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis 1987; 135: 223-229.
2. Innocenti F, Fabbri A, Anichini R, et al. Indications of reduced pulmonary function in type I (insulin-dependent) diabetes mellitus. Diabetes Res Clin Pract 1994; 25: 161-168.
3. Russ RD, Tobin BW. Alteration of segmental vascular resistance in the pulmonary circulation of diabetic rats. Can J Physiol Pharmacol 1996; 74: 1010-1015.
4. Irizar A, Ioannides C. Extrahepatic expression of P450 proteins in insulin-dependent diabetes mellitus. Xenobiotica 1995; 25: 941-949.
5. Ofulue AF, Khadempour MH, Thurlbeck WM. Diminished levels of insulin-like growth factor-I in lungs in streptozotocin-induced diabetes: relation to nutritional status and growth. Exp Lung Res 1994; 20: 27-40.
6. Erman A, van Dyk DJ, Chen-Gal B, et al. Angiotensin converting enzyme activity in the serum, lung and kidney of diabetic rats. Eur J Clin Invest 1993; 23: 615-620.
7. Myint T, Hoshi S, Ookawara T, et al. Immunological detection of glycated proteins in normal and streptozotocin-induced diabetic rats using anti-hexitol-lysine IgG. Biochim Biophys Acta 1995; 1272: 73-79.
8. Vracko R, Thorning D, Huang TW. Basal lamina of alveolar epithelium and capillaries: quantitative changes with aging and diabetes mellitus. Am Rev Respir Dis 1979; 120: 973-983.
9. Kida K, Utsuyama M, Takizawa T, et al. Changes in lung morphologic features and elasticity caused by streptozotocin-induced diabetes mellitus in growing rats. Am Rev Respir Dis 1983; 128: 125-131.
10. Crouch EC, Martin GR, Brody JS. Basement membranes. In: Crystal RG, West JB, Barens PJ, Weibel ER, eds. The Lung: Scientific Foundations. Philadelphia, New York, Lippincott-Raven Press, 1997; pp. 769-791.
11. Farina J, Furio V, Fernandez-Acenero MJ, et al. Nodular fibrosis of the lung in diabetes mellitus. Virchows Arch 1995; 427: 61-63.
12. Guttentag SH, Phelps DS, Stenzel W, et al. Surfactant protein A expression is delayed in fetuses of streptozotocin-treated rats. Am J Physiol 1992; 262: L489-L494.
13. Guttentag SH, Phelps DS, Warshaw JB, et al. Delayed hydrophobic surfactant protein (SP-B, SP-C) expression in fetuses of streptozotocin-treated rats. Am J Respir Cell Mol Biol 1992; 7: 190-197.
14. Colpaert C, Hogan J, Stark AR, et al. Increased muscularization of small pulmonary arteries in preterm infants of diabetic mothers: a morphometric study in noninflated, noninjected, routinely fixed lungs. Pediatr Pathol Lab Med 1995; 15: 689-705.
15. Moutschen MP, Scheen AJ, Lefebre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 1992; 18: 187-201.
16. Westphal SA, Sarosi GA. Diabetic ketoacidosis associated with pulmonary coccidioidomycosis. Clin Infect Dis 1994; 18: 974-978.
17. Thomas WA, O'Neal RM, Lee KT. Thromboembolism, pulmonary arteriosclerosis, and fatty meals: an experimental study of the effect of intermittent fatty meals on thromboembolic-induced pulmonary arteriosclerosis in rabbits. Arch Pathol 1956; 61: 380-389.
18. Heptinstall RH. Experimental pulmonary atheroma. J Path Bact 1957; 77: 535-542.
19. Komuro K, Rosenzweig DY. Experimental production of pulmonary hypertension and pulmonary atherosclerosis in the rabbit. Circ Res 1967; 20: 545-551.
20. Gilligan JP, Langner RO. Effect of removal of atherogenic diet on protein synthesis and cholesterol retention in rabbit aorta and lung. Atherosclerosis 1985; 54: 1-10.
21. Bailey JM, Makheja AN, Lee R, et al. Systemic activation of 15-lipoxygenase in heart, lung and vascular tissues by hypercholesterolemia: relationship to lipoprotein oxidation and atherogenesis. Atherosclerosis 1995; 113: 247-258.
22. Ruan Y, Takahashi K, Naito M. Immunohistochemical detection of macrophage-derived foam cells and macrophage colony-stimulating factor in pulmonary atherogenesis of cholesterol-fed rabbits. Pathol Int 1995; 45: 185-195.
23. Williamson JR, Rowold E, Huffman P, et al. Influence of fixation and morphometric techniques on capillary basement membrane thickening. Prevalence data in diabetes. Diabetes 1976; 25: 604-613.
24. Simionescu M, Popov D, Sima A, et al. Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model: the hyperlipidemic-hyperglycemic hamster. Am J Pathol 1996; 148: 997-1014.
25. Raz I, Havivi Y, Yarom R. Reduced negative surface charge on arterial endothelium of diabetic rats. Diabetologia 1988; 31: 618-620.
26. Popov D, Sima A, Stern D, et al. The pathomorphological alterations of endocardial endothelium in experimental diabetes, and diabetes associated with hyperlipidemia. Acta Diabetol 1996; 33: 41-47.
27. Katayama M, Hirai S, Kalo I, et al. Immunoenzymometric analysis for plasma von Willebrand factor degradation in diabetes mellitus using monoclonal antibodies recognizing protease-sensitive sites. Clin Biochem 1994; 27: 123-131.
28. Warner AE, Brain JD. The cell biology and pathogenic role of pulmonary intravascular macrophages. Am J Physiol 1990; 258: L1-L12.
29. Hussain MJ, Peakman M, Gallati H, et al. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 1996; 39: 60-69.
30. Simionescu M. Cellular organization of the alveolar-capillary unit: structural-functional correlations. In: Said SI, ed. The Pulmonary Circulation and Acute Lung Injury. 2nd Edn. Mount Kisco, NY, Futura Publishing Co. Inc., 1991; pp. 13-42.
31. Bellmunt MJ, Portera M, Pamplona R, et al. Evidence for the Maillard reaction in rat lung collagen and its relationship with solubility and age. Biochim Biophys Acta 1995; 1272: 53-60.
32. Stevens EJ, Willars GB, Lindbury P, et al. Vasoreactivity and prostacyclin release in streptozotocin-diabetic rats: effects of insulin or aldose reductase inhibition. Br J Pharmacol 1993; 109: 980-986.